Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008216HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10026116HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048269HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048270HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052479HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052709HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30084289HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30088779HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30018326HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30026961HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB03128
Drug NameAcetylcholine
Target IDBE0000045
UniProt IDP20309
Regulation Type
PubMed IDs10101037
CitationsBirdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, Sugimoto M: Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol Pharmacol. 1999 Apr;55(4):778-86.
GroupsApproved; Investigational
Direct ClassificationAcyl cholines
SMILESCC(=O)OCC[N+](C)(C)C
PathwaysFamotidine Action Pathway; Nizatidine Action Pathway; Esomeprazole Action Pathway; Pantoprazole Action Pathway; Ranitidine Action Pathway; Gastric Acid Production; Pirenzepine Action Pathway; Omeprazole Action Pathway; Lafutidine H2-Antihistamine Action; Rabeprazole Action Pathway; Phospholipid Biosynthesis; Betazole Action Pathway; Metiamide Action Pathway; Cimetidine Action Pathway; Roxatidine Acetate Action Pathway; Lansoprazole Action Pathway
PharmGKBPA448031
ChEMBLCHEMBL667